An upcoming international position statement will clarify the small number of patients for whom the MiniMed Implantable ...
The expanded approval was based on data from the phase 3 PRONTO-PUMP-2 trial which evaluated Lyumjev vs Humalog for use in insulin pump therapy in 432 adults with type 1 diabetes. The Food and Drug ...
Individuals living with type 1 diabetes must carefully follow prescribed insulin regimens every day, receiving injections of the hormone via syringe, insulin pump or some other device. And without ...
A breakthrough zwitterionic polymer slips through the skin’s toughest barriers, carrying insulin deep into tissue and normalizing blood sugar, offering patients a painless alternative to daily ...
Unexplained hyperglycemic events may be due to undetected occlusions, a common problem that experts say needs to be addressed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results